MSH2 and colorectal carcinoma: When we compare our estimates of time to CRC with the results obtained by Alarcon et al. (Figure 2, combined MSH2 and MLH1 families), our risk estimates at ages 30, 50 and 70 years are consistently higher for both male and female carriers but the wide 95% confidence intervals do overlap for each gender.